AIFA, the drug regulator in Italy, has approved the use of Moderna's (Nasdaq:MRNA) COVID-19 vaccine for children 12-17 years old, Reuters news agency reported on Wednesday.
This is the second vaccine endorsed for adolescents in Italy, alongside that of Pfizer.
The Italian drug regulator stated that it had endorsed the vaccine Spikevax for teens, fully accepting the recommendation made by the European Medicines Agency (EMA) on 23 July 2021,
AIFA added that "The available data demonstrate the efficacy and safety of the vaccine also for subjects in this age group."
Lipogems completes patient enrolment in ARISE I US FDA IDE study
Amylyx Pharmaceuticals' AMX0035 shows promising impact on Wolfram syndrome symptoms
Ondine Biomedical's Steriwave approved for use by HCA UK
Roche attains CE Mark for first companion diagnostic for HER2-low metastatic breast cancer
Cadrenal Therapeutics' tecarfarin receives US FDA Orphan Drug Designation
BioCity Biopharma's BC2027 Phase one study IND application receives US FDA approval
Seres Therapeutics completes patient enrollment for SER-155 Phase 1B trial
Syros receives Fast Track Designation from FDA for tamibarotene in AML
Ligand Pharmaceuticals announces presentation of Captisol-enabled Topiramate Injection data